I am assuming that is what you are referring to...We are aware that Abbott is pursuing late stage clinical testing of DuoDopa, as required by the FDA. Recent news items indicate that Abbott may plan to submit for FDA approval sometime late this year. As with the entire PD community, MJFF is eager to see the results of the clinical trial and hopes that results will be positive to lead to a filing and that DuoDopa can be made available to patients in the US. At this point, although frustrating, we have to let the process run, let the trial be completed and results analyzed to move forward on FDA submission.

Debi